VEXUS and Assessment of Dry Weight of Patients on Hemodialysis
Contribution of Lung Ultrasound and VExUS Score in Assessment of Volume Status in Maintenance Hemodialysis Patients.
1 other identifier
interventional
40
1 country
1
Brief Summary
This is a prospective, single-arm study that will be conducted over a period of 24 weeks. The same maintenance HD patients will be followed sequentially in two study phases, with each patient serving as their own control. The study aims to evaluate the role of POCUS, including LUS and VExUS score, in improving the assessment of volume status and determination of dry weight in patients undergoing maintenance HD. Phase I (Weeks 1-12): Clinical Assessment Phase During the first 12 weeks, all patients will be managed using standard clinical assessment alone. Determination of dry weight and calculation of target ultrafiltration (UF) will rely primarily on clinical parameters, including physical examination and routine clinical judgment. Phase II (Weeks 13-24): POCUS-guided assessment period During the second 12 weeks, the same patients will undergo POCUS assessment, including LUS and VExUS Score. LUS and VExUS examinations will be performed 30 minutes after the scheduled hemodialysis session. All measurements will be conducted during the mid-week dialysis session to reflect the average hydration status of each patient. At the end of each phase, the results of all patients will be correlated with assessment of dry weight by BIS (Inbody version 720). Inclusion criteria: ESRD patients on maintenance HD for more than three months. In the HD unit at Medical Research Institute and Faculty of Medicine. Alexandria University. Age: 25 -65 years old. The ability to give informed consent. Exclusion criteria:
- Patients with previous echocardiographic evidence of right heart dysfunction, tricuspid valve disease, or IVC thrombosis.
- Patients with liver cirrhosis
- Lung diseases: interstitial lung diseases, COPD patients.
- Obese (BMI≥30) Before inclusion in the study, all patients will be required to fill out a written informed consent. Also, approval from the Medical Ethics Committee will be obtained. Maintenance hemodialysis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 12, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
July 23, 2026
July 1, 2026
6 months
July 12, 2026
July 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change of patients dry weight between the two phases of the study
Change of patient dry weight (in KG ) measured by bioimpedance device between the two phases of the study
3 months
Study Arms (1)
Patients on maintenance hemodialysis
OTHERthe same patients will be used as their own control in two phase study where US will be used to determine patients dry weight
Interventions
usage of US to determine patient dry weight and ultrafiltration volume needed
Eligibility Criteria
You may qualify if:
- ESRD patients on maintenance HD for more than three months.
- In the HD unit at the Medical Research Institute and Faculty of Medicine. Alexandria University.
- Age: 25 -65 years old.
- The ability to give informed consent.
You may not qualify if:
- Patients with previous echocardiographic evidence of right heart dysfunction, tricuspid valve disease, or IVC thrombosis.
- Patients with liver cirrhosis
- Lung diseases: interstitial lung diseases, COPD patients.
- Obese (BMI≥30)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandria University Hospitals
Alexandria, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of internal medicine
Study Record Dates
First Submitted
July 12, 2026
First Posted
July 23, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
July 23, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
patients did not consent for sharing their data